Dr Ashleys Limited And Impact Biomedical Inc. Announce Strategic Merger
June 23 (Reuters) - Impact Biomedical Inc IBO.A:
DR ASHLEYS LIMITED AND IMPACT BIOMEDICAL INC. ANNOUNCE STRATEGIC MERGER
IMPACT BIOMEDICAL INC - TO BE RENAMED 'DR ASHLEYS USA INC.' - SEC FILING
IMPACT BIOMEDICAL INC - MERGER SUBJECT TO NYSE APPROVAL OF COMBINED COMPANY SHARES
IMPACT BIOMEDICAL INC - DR ASHLEYS SHAREHOLDER TO RECEIVE 94.20% OF PUBCO SHARES - SEC FILING
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
MSTR Stock Price Prediction 2026-2030: Is Strategy the Ultimate Bitcoin Leveraged Play?

SanDisk Surges 8% as Earnings Countdown Begins - Here's What Every Investor Needs to Know

Azure Growth 40%, AI Revenue 37 Billion: Why Did Microsoft Shares Fall Instead of Rise?

Nvidia Stock Prediction: Can NVDA Hit $1,000 by 2030?

Robinhood Slumps 8% After Earnings. Revenue and Profit Both Miss, Market Fears Coinbase May Follow Suit.

Tradingkey







